(Q53284274)

English

Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis.

scientific article published on 20 October 2011

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Expression of the nuclear bile acid receptor/farnesoid X receptor is reduced in human colon carcinoma compared to nonneoplastic mucosa independent from site and may be associated with adverse prognosis. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

colon carcinoma

1 reference

based on heuristic

inferred from title

Michael Trauner

8

object named as

Michael Trauner

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

author name string

Sigurd Lax

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Georg Schauer

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Kurt Prein

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Magdalena Kapitan

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Dagmar Silbert

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Andrea Berghold

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

Anton Berger

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

language of work or name

0 references

publication date

20 October 2011

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

International Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

130

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

2232-2239

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

A genetic model for colorectal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Role of bile acid secretion in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Bile acids stimulate invasion and haptotaxis in human colorectal cancer cells through activation of multiple oncogenic signaling pathways

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Inhibition of proliferation and induction of monocytic differentiation on HL60 human promyelocytic leukemia cells treated with bile acids in vitro

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Bile acids and derivatives, their nuclear receptors FXR, PXR and ligands: role in health and disease and their therapeutic potential

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Farnesoid X receptor deficiency in mice leads to increased intestinal epithelial cell proliferation and tumor development

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Nuclear bile acid receptor FXR protects against intestinal tumorigenesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

The bile acid nuclear receptor FXR and the bile acid binding protein IBABP are differently expressed in colon cancer

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

FXR, a multipurpose nuclear receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

FXR: a metabolic regulator and cell protector

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

FXR signaling in metabolic disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Wnt control of stem cells and differentiation in the intestinal epithelium

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Nuclear receptors, intestinal architecture and colon cancer: an intriguing link

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Spontaneous development of liver tumors in the absence of the bile acid receptor farnesoid X receptor

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Association between farnesoid X receptor expression and cell proliferation in estrogen receptor-positive luminal-like breast cancer from postmenopausal patients

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

The farnesoid X receptor is expressed in breast cancer and regulates apoptosis and aromatase expression

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

The intestinal nuclear receptor signature with epithelial localization patterns and expression modulation in tumors.

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Nuclear bile acid receptor FXR as pharmacological target: are we there yet?

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Bile acids and their nuclear receptor FXR: Relevance for hepatobiliary and gastrointestinal disease

1 reference

https://api.crossref.org/works/10.1002%2FIJC.26293

21 January 2018

Identifiers

10.1002/IJC.26293

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/21780109

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53284274&oldid=1859303625"